San Diego, CA, United States of America

Yang Tran

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Receptos, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yang Tran. Retrieved from https://idiyas.com/inventor/yang-tran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yang Tran - Innovator in Pharmaceutical Compounds

Introduction

Yang Tran is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on receptor agonists.

Latest Patents

Yang Tran holds a patent for CXCR3 receptor agonists. This patent includes compounds that have a specific structure defined in Formula I, where R, R, R, R, and R are as defined in the documentation. The patent also covers pharmaceutical compositions that comprise these compounds, along with methods related to their manufacture and use.

Career Highlights

Yang Tran is currently employed at Receptos, Inc., where he continues to advance his research and development efforts in the pharmaceutical industry. His work has the potential to impact various therapeutic areas significantly.

Collaborations

Yang has collaborated with notable colleagues, including Adam Richard Yeager and Philip Turnbull, contributing to a dynamic research environment.

Conclusion

Yang Tran's innovative work in the development of CXCR3 receptor agonists showcases his commitment to advancing pharmaceutical science. His contributions are poised to make a lasting impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…